Navigation Links
EdeniQ Licenses Yeast Technology from USDA
Date:6/14/2011

VISALIA, Calif., June 14, 2011 /PRNewswire/ -- EdeniQ, Inc., a California-based clean technology company serving the global biofuels industry, announced today that it has licensed yeast technology from the USDA Forest Products Laboratory (FPL) and the Wisconsin Alumni Research Foundation (WARF) associated with the fermentation of C5 sugars, such as xylose, to ethanol.  The license marks the culmination of the 3-year Cooperative Research and Development Agreement (CRADA) between FPL and EdeniQ.  EdeniQ plans to evaluate the yeast technology which will be showcased in EdeniQ's DOE-funded, 2 ton per day cellulosic ethanol pilot plant, which is currently under construction and scheduled for startup in Q1 2012. The two groups have also agreed to continue their R&D collaboration in yeasts under a new two-year CRADA.    

(Logo:  http://photos.prnewswire.com/prnh/20110614/SF19106LOGO)

"We have been pleased by the fruitful cooperation between our scientists and FPL, and its continuation under the new CRADA," said Dr. Thomas Griffin, Vice President, Technology at EdeniQ.  "The FPL technology for fermenting C5 sugars is synergistic with our current C6 yeasts and complements our integrated technology package."  

"This technology represents an important breakthrough in improving the conversion of C5 sugars to ethanol," added Dr. Thomas Jeffries, FPL's Principal Investigator and leader of the FPL team.  "We look forward to the continuing partnership with EdeniQ to enhance and commercialize these yeasts."

The USDA Forest Products Labs operates in cooperation with the University of Wisconsin-Madison. The Wisconsin Alumni Research Foundation the private, nonprofit patent and licensing organization for the University of Wisconsin-Madison, acted as licensor on behalf of FPL and the University.


'/>"/>
SOURCE EdeniQ, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Interleukin Genetics Licenses its PST(R) Genetic Test to OralDNA Labs
2. Access Pharmaceuticals Licenses MuGard to Milestone Biosciences, LLC for North America
3. MedImmune Licenses Reverse Genetics Technology to Hungarys Omninvest for Use in Influenza Vaccine Development and Production
4. Onyx Pharmaceuticals Licenses Rights to Novel Targeted Oncology Agent From BTG International
5. Stem Cell Sciences Licenses Stem Cell Technology to Leading Provider of Genetically Modified Models for Pharmaceutical Research
6. Arizona Heart Innovative Technologies Licenses New Endovascular Device
7. BioWa Licenses POTELLIGENT(R) Technology to GlaxoSmithKline for Use in Antibody Development and Commercialization
8. Artemis Health Licenses Prenatal Cell-Free DNA Analysis Technology from Stanford University
9. Implicit Licenses Clinical Stage Antibody Program From Lilly
10. Global Med Technologies(R) Licenses 90th Site in the Southeastern U.S.
11. Nanosys Licenses Nanowire Technology to QuantuMDx Group for Next Generation Diagnostic and Sequencing Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... Belgium , Nov. 24, 2014 ... focused on developing diagnostic tests for cancer and other conditions, ... will be presented at the Science for Business BioWin Day ... Belgium . The data come from VolitionRx,s lung cancer ... Pneumology department of the Centre Hospitalier Universitaire (CHU) de Liege ...
(Date:11/24/2014)... FRANCISCO, Calif. , Nov. 24, 2014   Veracyte, ... Bonnie H. Anderson , president and chief executive officer, ... Jaffray 26 th Annual Healthcare Conference on Tuesday, December ... York . The live audio webcast and ... http://investor.veracyte.com . Please connect to the website at least ...
(Date:11/24/2014)... Continental Clinical Solutions, LLC (Continental) ... trials at its mid-Atlantic late-phase research facility, located ... with the idea of closing patient disparities in ... medical advances," said Continental's CEO, Saleh Stevens ... immortal cell line of Henrietta Lacks, dubious ethical ...
(Date:11/24/2014)... (PRWEB) November 24, 2014 The ... ” from METTLER TOLEDO demonstrates how to reduce ... Power analytics and sample panel design can be ... chemistry and protect against corrosion and deposition. Dedicated ... a significant amount of panel space. Additionally, installing ...
Breaking Biology Technology:VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 2VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 3VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 4VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 5VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 6Veracyte to Present at the Piper Jaffray 26th Annual Healthcare Conference 2At Continental Clinical Solutions, CEO Saleh Stevens Focuses on Diversity in Clinical Trial Recruitment at Maryland Site 2At Continental Clinical Solutions, CEO Saleh Stevens Focuses on Diversity in Clinical Trial Recruitment at Maryland Site 3New Video Shows How to Simplify Cycle Chemistry Sample Panels to Save Time and Costs 2
... 22 Maven Biotechnologies, LLC,an early stage ... system, today announced that the company will,deliver ... in San Diego,California. Jeffrey C. Travis, Ph.D., ... November 1, 2007 at 3:30 PM. ...
... Called Upon to Help One Deserving Facility Win Needed Medical ... Its Favorite ,Clinical Contender, MALVERN, Pa., Oct. 22 ... of the clinical challenges in hospitals,across the country to millions ... technology - a magnetic resonance imaging,(MRI) system - are being ...
... PCOP ), an innovator in the discovery and ... Leslie J. Browne,President and Chief Executive Officer, will deliver ... 9th Annual Healthcare,Conference. The conference will be held November ... in New York City. Dr. Browne,s presentation will ...
Cached Biology Technology:Maven Biotechnologies, LLC to Present at BIOCOM Investor Conference 2American M.R.I.-DOL: Small Hospitals To Turn The Camera On Themselves In Unique National Contest 2American M.R.I.-DOL: Small Hospitals To Turn The Camera On Themselves In Unique National Contest 3Pharmacopeia to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 2Pharmacopeia to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 3Pharmacopeia to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 4
(Date:11/18/2014)... -- The Secure Identity & Biometrics Association (SIBA) and ... formation of The Airport Entry and Exit Working ... Biometric Entry and Exit Solutions Framework for Airports ... BORDERPOL, the international non-profit organization that works directly ... border security, traveler and migration systems. ...
(Date:11/12/2014)... PALM BEACH GARDENS, Fla. , Nov. 12, 2014 ... management solutions, announced today that its U.are.U ® ... upscale retail bakery chain in Central Mexico ... solution in June 2014 to eliminate payroll issues caused ... Prior to installing the U.are.U fingerprint readers, Montparnasse ...
(Date:11/7/2014)... -- Leading Biometric companies aim to provide consumers ... transactions.  Companies in focus today are: NXT-ID, Inc. (NASDAQ: ... ), Google Inc. (NASDAQ: GOOG ), Microsoft Corporation ... EBAY ) and MasterCard Inc. (NYSE: MA) NXT-ID, ... authentication company focused on the growing mobile commerce is pleased ...
Breaking Biology News(10 mins):Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 3Montparnasse Pasteleria Achieves Time and Attendance Transparency with Crossmatch U.are.U Fingerprint Readers 2Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 2Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 3Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 4Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 5Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 6
... scientists studying genetic pathways that are mutated in many ... of congenital heart disease including hypertrophic cardiomyopathy (HCM), ... leading cause of sudden death in children and young ... successfully treated HCM in the lab. In ...
... of California, Davis, will present these findings at ... the Advancement of Science in Washington, D.C., on ... from the Transportation Sector, Presenter: Christopher Yang, UC ... Friday, Feb. 18, 2 p.m., Location: 206 Washington ...
... biologist Graham Walker leads a research group focused on ... excitement of his research lab: doctoral and graduate students ... new research questions in science education and brainstorm ways ... his experiences running a science education research group and ...
Cached Biology News:Cancer-related pathways reveal potential treatment target for congenital heart disease 2Cancer-related pathways reveal potential treatment target for congenital heart disease 3AAAS news briefs from UC Davis 2AAAS news briefs from UC Davis 3AAAS news briefs from UC Davis 4AAAS news briefs from UC Davis 5Plenary speech by HHMI professor highlights efforts of scientist-educators 2Plenary speech by HHMI professor highlights efforts of scientist-educators 3
Mouse monoclonal antibody raised against a partial recombinant COG2. NCBI Entrez Gene ID = COG2...
Mouse polyclonal antibody raised against a partial recombinant IFNA13. NCBI Entrez Gene ID = 3447...
Mouse monoclonal antibody raised against a full length recombinant LDB3. NCBI Entrez Gene ID = LDB3...
Mouse polyclonal antibody raised against a partial recombinant NCLN. NCBI Entrez Gene ID = 56926...
Biology Products: